February 27, 2025

ASTRO Issues Clinical Guideline on Radiation Therapy for Anal Cancer

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on the use of radiation therapy to treat adult patients with primary squamous cell carcinoma of the ...

The ASCO Post

February 21, 2025

I’m a 2.0 Version of Myself After Cancer

Although there’s no history of breast cancer in my family, when I was 10, my pediatrician introduced me to breast self-exams, so I would become familiar with my breasts and learn to spot any unusual c...

The ASCO Post

February 21, 2025

Exercise Therapy as Candidate Anticancer Strategy

Lee Jones, PhD, Head of the Exercise Oncology Program at Memorial Sloan Kettering Cancer Center, shared findings from an early-phase clinical trial to determine the feasibility, safety, and tumor biol...

The ASCO Post

February 21, 2025

Cancer Mortality Rates Continue to Decline, Incidence Rates in Women Rise, and Racial Disparities Persist

The findings in the American Cancer Society (ACS) annual report, Cancer Statistics, 2025,1 showed a mixed trend in cancer incidence and mortality rates. Although cancer mortality declined by 34% from ...

The ASCO Post

February 19, 2024

FDA Grants Accelerated Approval to Lifileucel for Unresectable or Metastatic Melanoma

On February 16, the FDA granted accelerated approval to lifileucel (Amtagvi), a tumor-derived autologous T-cell immunotherapy, for previously treated adult patients with unresectable or metastatic mel...

The ASCO Post

February 16, 2023

Blinatumomab Improves Survival in MRD-Negative, B-Cell ALL

The standard of care could be changing for adults with newly diagnosed BCR-ABL–negative B-lineage acute lymphoblastic leukemia who achieve measurable residual disease (MRD) negativity after induction ...

The ASCO Post

January 25, 2023

Expert Point of View: Jeremy S. Abramson, MD

Dr. Jeremy S. Abramson, Director of Lymphoma at Mass General Cancer Center, discusses the clinical implications of the TRIANGLE study, emphasizing the potential advancements in frontline therapy for younger patients with mantle cell lymphoma.

The ASCO Post

January 25, 2023

Atrium Health and Wake Forest University School of Medicine Cancer Program Appoint New Director

Atrium Health appoints Dr. Ruben A. Mesa as President and Executive Director of its cancer service line, bringing extensive expertise in hematology research and drug development to advance cancer health equity and diversity in cancer clinical trials.

The ASCO Post

September 01, 2023

A Career in Cardio-oncology Founded on Simple Principles Taught by Her Immigrant Parents

Cardio-oncology focuses on the detection, monitoring, and treatment of cardiovascular disease occurring secondary to cancer treatment, and the mechanistic and epidemiologic intersection between cardio...

The ASCO Post